Market Research Report
Electrocardiography (ECG) - Global Market Outlook (2016-2022)
|Published by||Stratistics Market Research Consulting||Product code||521505|
|Published||Content info||142 Pages
Delivery time: 1-2 business days
|Electrocardiography (ECG) - Global Market Outlook (2016-2022)|
|Published: February 1, 2017||Content info: 142 Pages||
According to Stratistics MRC, the Global Electrocardiography (ECG) Market accounted for $XX million in 2016 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2016 to 2022. Rising incidences of cardiovascular & lifestyle diseases, favourable government regulations, technological advancements and rising geriatric population are some of the key factors fuelling the market growth. Moreover, increasing demand for portable monitoring & diagnostic devices and recent R&D investments by top players in heart disease detection systems is supporting the growth of Electrocardiography (ECG) market. However, market saturation, high cost of devices and unstable reimbursement policies are some of the factors hindering the market.
By lead type, 3-6 Lead ECG segment is expected to dominate the overall Electrocardiography (ECG) market in 2015 and is projected to sustain its growth over the forecast period. North America is anticipated to be the largest market for Electrocardiography (ECG), whereas Asia Pacific is projected to grow at a faster pace.
Some of the major players in the Electrocardiography (ECG) market are Medtronic, Inc., Bionet, Cardiac Science, Royal Philips Healthcare, Lifewatch AG, GE Healthcare, Nihon, Kohden Corporation, Boston Scientific, Compumed Inc., Mortara Instrument, Inc., Welch Allyn, Cardionet Inc., Schiller AG, Spacelabs Healthcare Inc., St. Jude Medical, Inc. and Mindray Medical International Limited.
Lead Types Covered:
End Users Covered:
What our report offers: